ADiTx Therapeutics, Inc.
ADiTx Therapeutics, Inc. (ADTX) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 40 transactions totaling $780.9K, demonstrating a bearish sentiment with -$601.5K in net insider flow. The most recent transaction on Dec 17, 2025 involved a sale of 1 shares valued at $2.
ADTX Insider Activity Summary
Who Is Buying ADTX Stock?
No significant insider buying has been recorded for ADTX in the recent period.
Who Is Selling ADTX Stock?
No significant insider selling has been recorded for ADTX in the recent period.
Is ADiTx Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ADTX is bearish with an Insider Alignment Score of 11/100 and a net flow of -$601.5K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ADTX Frequently Asked Questions
Understanding ADTX Insider Activity
Insider trading at ADiTx Therapeutics, Inc. (ADTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading ADTX stock, having executed 40 transactions in the past 90 days. The most active insider is Amro A. Albanna (Executive), who has made 10 transactions totaling $858.1K.
Related Tools
Track ADiTx Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ADTX file new Form 4 transactions